PCLO — Pharmacielo Balance Sheet
0.000.00%
Last trade - 00:00- CA$8.46m
- CA$30.64m
- CA$3.97m
- 14
- 35
- 18
- 10
Annual balance sheet for Pharmacielo, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.61 | 5.63 | 0.326 | 0.062 | 0.054 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.924 | 0.565 | 0.671 | 0.761 | 0.958 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 12.5 | 9.2 | 4.02 | 3.33 | 2.41 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 30.8 | 26.1 | 20.6 | 18.7 | 16.1 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 44 | 36 | 25.1 | 22.3 | 18.5 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.1 | 8.07 | 6.95 | 21.4 | 23.4 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 17.8 | 16.6 | 18.7 | 24 | 28 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 26.2 | 19.3 | 6.39 | -1.68 | -9.49 |
| Total Liabilities & Shareholders' Equity | 44 | 36 | 25.1 | 22.3 | 18.5 |
| Total Common Shares Outstanding |